Related Experiment Video
Updated: Aug 7, 2026

07:58
Induction and Assessment of Ischemia-reperfusion Injury in Langendorff-perfused Rat Hearts
Published on: July 27, 2015
Reperfusion in acute myocardial infarction: current concepts
Demosthenes Katritsis1, Evangelia Karvouni, Michael M Webb-Peploe
1Department of Cardiology, Athens Euroclinic, Athens, Greece. dkatrits@otenet.gr
Progress in Cardiovascular Diseases
|June 12, 2003
Summary
Primary angioplasty with stenting offers superior outcomes for acute myocardial infarction compared to thrombolysis alone. Facilitated angioplasty shows promise, with ongoing trials evaluating its efficacy and safety.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Myocardial reperfusion is crucial for treating acute myocardial infarction (AMI).
- Pharmacological thrombolysis achieves coronary artery patency in approximately two-thirds of AMI patients.
- Mechanical reperfusion via primary angioplasty and stenting demonstrates higher patency rates and fewer complications, particularly in high-risk individuals.
Purpose of the Study:
- To compare the effectiveness of different reperfusion strategies in acute myocardial infarction.
- To evaluate the potential of facilitated angioplasty as a treatment for AMI.
Main Methods:
- Review of current treatment options for myocardial reperfusion.
- Discussion of adjunctive pharmacotherapy and device technology in primary angioplasty.
- Exploration of facilitated angioplasty protocols including thrombolysis and glycoprotein IIb/IIIa inhibitors.
Main Results:
- Primary angioplasty and stenting yield higher coronary artery patency rates than thrombolysis.
- Mechanical reperfusion is associated with fewer complications, especially in high-risk AMI patients.
- Facilitated angioplasty represents a promising strategy currently under investigation.
Conclusions:
- Mechanical reperfusion, particularly primary angioplasty and stenting, is the preferred treatment for acute myocardial infarction.
- Adjunctive therapies and novel devices may further enhance primary angioplasty outcomes.
- Facilitated angioplasty warrants further evaluation in ongoing clinical trials for AMI management.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...

